|
[1]
|
Benson, A.B., Venook, A.P., Al-Hawary, M.M., et al. (2022) Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 20, 1139-1167. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Siegel, R.L., Wagle, N.S., Cercek, A., Smith, R.A. and Jemal, A. (2023) Colorectal Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 233-254. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Bretthauer, M., Løberg, M., Wieszczy, P., et al. (2022) Effect of Colonos-copy Screening on Risks of Colorectal Cancer and Related Death. The New England Journal of Medicine, 387, 1547-1556. [Google Scholar] [CrossRef]
|
|
[4]
|
Kratzer, T.B., Jemal, A., Miller, K.D., et al. (2022) Cancer Statistics for American Indian and Alaska Native Individuals, 2022: Including Increasing Disparities in Early Onset Colorectal Cancer. CA: A Cancer Journal for Clinicians, 73, 120-146. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Yan, H., Talty, R. and Johnson, C.H. (2023) Targeting Ferroptosis to Treat Colorectal Cancer. Trends in Cell Biology, 33, 185-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Mo, S., Tang, P., Luo, W., et al. (2022) Patient-Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy. Advanced Science (Weinh), 9, Article ID: 2204097. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Sakata, S. and Larson, D.W. (2022) Targeted Therapy for Colorectal Cancer. Surgical Oncology Clinics of North America, 31, 255-264. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
He, J., Liu, Y., Liu, C., et al. (2023) A Randomized Phase III Study of Anlotinib versus Bevacizumab in Combination with CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol. Technology in Cancer Research & Treatment, 22, 15330338231152350 [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
West, N.P., Hohenberger, W., Weber, K., Perrakis, A., Finan, P.J. and Quirke, P. (2010) Complete Mesocolic Excision with Central Vascular Ligation Produces an Oncologically Su-perior Specimen Compared with Standard Surgery for Carcinoma of the Colon. Journal of Clinical Oncology, 28, 272-278. [Google Scholar] [CrossRef]
|
|
[10]
|
Cervantes, A., Adam, R., Roselló, S., et al. (2023) Meta-static Colorectal Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up. Annals of Oncolo-gy, 34, 10-32. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Zhao, W., Dai, S., Yue, L., et al. (2022) Emerging Mechanisms Progress of Colorectal Cancer Liver Metastasis. Frontiers in Endocrinology (Lausanne), 13, Article ID: 1081585. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Islam, M.R., Akash, S., Rahman, M.M., et al. (2022) Colon Cancer and Colorectal Cancer: Prevention and Treatment by Potential Natural Products. Chemico-Biological Inter-actions, 368, Article ID: 110170. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Xu, H., Zhao, H., Ding, C., et al. (2023) Celastrol Suppresses Col-orectal Cancer via Covalent Targeting Peroxiredoxin 1. Signal Transduction and Targeted Therapy, 8, Article No. 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Karpiński, T.M., Ożarowski, M. and Stasiewicz, M. (2022) Car-cinogenic Microbiota and Its Role in Colorectal Cancer Development. Seminars in Cancer Biology, 86, 420-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zhang, C., Stampfl-Mattersberger, M., Ruckser, R. and Sebesta, C. (2023) Kolorektales Karzinom [Colorectal Cancer]. Wiener Medizinische Wochenschrift, 173, 216-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hryhorowicz, S., Kaczmarek-Ryś, M., Lis-Tanaś, E., et al. (2022) Strong Hereditary Predispositions to Colorectal Cancer. Genes (Basel), 13, Article No. 2326. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Cheng, V., Oveisi, N., McTaggart-Cowan, H., et al. (2022) Colorectal Cancer and Onset of Anxiety and Depression: A Systematic Review and Meta-Analysis. Current Oncology, 29, 8751-8766. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lote, H., Starling, N., Pihlak, R. and Gerlinger, M. (2022) Advances in Immunotherapy for MMR Proficient Colorectal Cancer. Cancer Treatment Reviews, 111, Article ID: 102480. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Lepore Signorile, M., Grossi, V., Fasano, C. and Simone, C. (2023) Colorectal Cancer Chemoprevention: A Dream Coming True? International Journal of Molecular Sciences, 24, Article No. 7597. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Aljama, S., Lago, E.P., Zafra, O., et al. (2023) Dichotomous Colorectal Cancer Behaviour. Critical Reviews in Oncology/Hematology, 189, Article ID: 104067. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Gogoi, P., Kaur, G. and Singh, N.K. (2022) Nanotechnology for Colorectal Cancer Detection and Treatment. World Journal of Gastroenterology, 28, 6497-6511. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kastrinos, F., Kupfer, S.S. and Gupta, S. (2023) Colorectal Cancer Risk Assessment and Precision Approaches to Screening: Brave New World or Worlds Apart? Gastroenterology, 164, 812-827. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ballester, V. and Cruz-Correa, M. (2022) Approach to Familial Predisposition to Colorectal Cancer. Gastroenterology Clinics of North America, 51, 593-607. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Holm, T. (2014) Controversies in Abdominoperineal Excision. Sur-gical Oncology Clinics of North America, 23, 93-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Andrade-Meza, A., Arias-Romero, L.E., Armas-López, L., et al. (2023) Mexican Colorectal Cancer Research Consortium (MEX-CCRC): Etiology, Diagnosis/Prognosis, and Innovative Therapies. International Journal of Molecular Sciences, 24, Article No. 2115. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Yamada, K., Ogata, S., Saiki, Y., Fukunaga, M., Tsuji, Y. and Takano, M. (2009) Long-Term Results of Intersphincteric Resection for Low Rectal Cancer. Diseases of the Colon and Rectum, 52, 1065-1071. [Google Scholar] [CrossRef]
|
|
[27]
|
Feizi, H., Rezaee, M.A., Ghotaslou, R., et al. (2023) Gut Microbiota and Colorectal Cancer Risk Factors. Current Pharmaceutical Biotechnology, 24, 1018-1034. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wu, Y., Xie, M., Sun, J.H., et al. (2022) Cellular Se-nescence: A Promising Therapeutic Target in Colorectal Cancer. Future Oncology, 18, 3463-3470. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Nagayama, S., Al-Kubati, W. and Sakai, Y. (2012) What Is the Place of Intersphincteric Resection When Operating on Low Rectal Cancer? ISRN Surgery, 2012, Article ID: 585484. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Leowattana, W., Leowattana, P. and Leowattana, T. (2023) Systemic Treatment for Metastatic Colorectal Cancer. World Journal of Gastroenterology, 29, 1569-1588. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Tufail, M. (2023) HOTAIR in Colorectal Cancer: Structure, Func-tion, and Therapeutic Potential. Medical Oncology, 40, Article No. 259. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Shihab, O.C., Moran, B.J., Heald, R.J., Quirke, P. and Brown, G. (2009) MRI Staging of Low Rectal Cancer. European radiology, 19, 643-650. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Niekamp, P. and Kim, C.H. (2023) Microbial Metabolite Dysbio-sis and Colorectal Cancer. Gut and Liver, 17, 190-203. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Yu, H.C., Peng, H., He, X.S. and Zhao, R.S. (2014) Comparison of Short- and Long-Term Outcomes after Extralevator Abdominoperineal Excision and Standard Abdominoperineal Excision for Rectal Cancer: A Systematic Review and Meta-Analysis. International Journal of Colorectal Disease, 29, 183-191. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Daca-Alvarez, M., Martí, M., Spinelli, A., et al. (2022) Familial Component of Early-Onset Colorectal Cancer: Opportunity for Prevention. British Journal of Surgery, 109, 1319-1325. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Liu, Y., Lau, H.C., Cheng, W.Y. and Yu, J. (2023) Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment. Genomics Proteomics Bioinformatics, 21, 84-96. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Dougherty, M.W. and Jobin, C. (2023) Intestinal Bacteria and Col-orectal Cancer: Etiology and Treatment. Gut Microbes, 15, Article ID: 2185028. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
How, P., West, N.P. and Brown, G. (2014) An MRI-Based Assessment of Standard and Extralevator Abdominoperineal Excision Specimens: Time for a Patient Tailored Approach? Annals of Surgical Oncology, 21, 822-828. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Laurberg, S. and Feddern, M.-L. (2015) Reconstructions after Neoadjuvant and Abdominoperineal Resection. In: Baatrup, G., Ed., Multidisciplinary Treatment of Colorectal Cancer, Springer International Publishing, Berlin, 99-104. [Google Scholar] [CrossRef]
|
|
[40]
|
Hu, B., Yin, Y., Li, S. and Guo, X. (2022) Insights on Fer-roptosis and Colorectal Cancer: Progress and Updates. Molecules, 28, Article No. 243. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Chen, L.J., Chen, X., Niu, X.H. and Peng, X.F. (2023) LncRNAs in Colorectal Cancer: Biomarkers to Therapeutic Targets. Clinica Chimica Acta, 543, Article ID: 117305.
|
|
[42]
|
Lulli, M., Napoli, C., Landini, I., Mini, E. and Lapucci, A. (2022) Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs. International Journal of Molecular Sciences, 23, Article No. 13431. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Bastid, C., Coron, E., Meyer, J., Ris, F., Meurette, G. and Koessler, T. (2023) Cancer Colorectal: Révolution Technologique [Colorectal Cancer: Technological Revolution]. Revue Médicale Suisse, 19, 938-943. [Google Scholar] [CrossRef]
|
|
[44]
|
Saraiva, M.R., Rosa, I. and Claro, I. (2023) Early-Onset Colorectal Cancer: A Review of Current Knowledge. World Journal of Gastroenterology, 29, 1289-1303. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Petrick, J.L., Barber, L.E. and Rosenberg, L. (2022) What Are the Factors Underlying Colorectal Cancer Health Disparities? Cancer Prevention Research (Phila), 15, 561-563. [Google Scholar] [CrossRef]
|
|
[46]
|
Lim, R.S., Yang, T.X. and Chua, T.C. (2014) Postopera-tive Bladder and Sexual Function in Patients Undergoing Surgery for Rectal Cancer: A Systematic Review and Me-ta-Analysis of Laparoscopic versus Open Resection of Rectal Cancer. Techniques in Coloproctology, 18, 993-1002. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Caspi, A., Entezari, A.A., Crutcher, M., Snook, A.E. and Wald-man, S.A. (2022) Guanylyl Cyclase C as a Diagnostic and Therapeutic Target in Colorectal Cancer. Personalized Medicine, 19, 457-472. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Sartore-Bianchi, A., Agostara, A.G., Patelli, G., Mauri, G., et al. (2022) Application of Histology-Agnostic Treatments in Metastatic Colorectal Cancer. Digestive and Liver Disease, 54, 1291. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Liu, Z., Xiang, Y., Zheng, Y. and Kang, X. (2022) Advancing Immune Checkpoint Blockade in Colorectal Cancer Therapy with Nanotechnology. Frontiers in Immunology, 13, Article ID: 1027124. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Ma, Y., Wang, B., He, P., et al. (2022) Coagulation- and Fibri-nolysis-Related Genes for Predicting Survival and Immunotherapy Efficacy in Colorectal Cancer. Frontiers in Immunology, 13, Article ID: 1023908. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Baraibar, I., Ros, J., Saoudi, N., et al. (2023) Sex and Gender Perspectives in Colorectal Cancer. ESMO Open, 8, Article ID: 101204. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Johansson, M. (2023) The Questionable Value of Colorectal Cancer Screening. BMJ, 380, Article No. 200. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Duek, S.D., Issa, N., Hershko, D.D. and Krausz, M.M. (2008) Outcome of Transanal Endoscopic Microsurgery and Adjuvant Radiotherapy in Patients with T2 Rectal Cancer. Diseases of the Colon and Rectum, 51, 379-384. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Elwali, N.E., Jarrah, O., Alzahrani, S.G., et al. (2023) Colorectal Cancer in Saudi Arabia: The Way Forward. Asian Pacific Journal of Cancer Prevention, 24, 13-19. [Google Scholar] [CrossRef]
|
|
[55]
|
Sajid, M.S., Farag, S., Leung, P., Sains, P., Miles, W.F. and Baig, M.K. (2014) Systematic Review and Meta-Analysis of Published Trials Comparing the Effectiveness of Transanal Endoscopic Microsurgery and Radical Resection in the Management of Early Rectal Cancer. Colorectal Disease: The Of-ficial Journal of the Association of Coloproctology of Great Britain and Ireland, 16, 2-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Rahmani, N., Pourali, G., Hosseini, N., et al. (2023) Probiotics as a Ther-apeutic Approach in Colorectal Cancer. Current Cancer Drug Targets, 23, 764-777. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Wang, X., Xu, Y., Dai, L., et al. (2022) A Novel Ox-idative Stress- and Ferroptosis-Related Gene Prognostic Signature for Distinguishing Cold and Hot Tumors in Colorectal Cancer. Frontiers in Immunology, 13, Article ID: 1043738. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Seva-Pereira, G. and Trombeta, V.L., Capochim Romagnolo, L.G. (2014) Transanal Minimally Invasive Surgery (TAMIS) Using a New Disposable Device: Our Initial Experience. Techniques in Coloproctology, 18, 393-397. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Martin-Perez, B., Andrade-Ribeiro, G.D., Hunter, L. and Atallah, S. (2014) A Systematic Review of Transanal Minimally Invasive Surgery (TAMIS) from 2010 to 2013. Techniques in Coloproctology, 18, 775-788. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Krishnan, T., Wang, F., Karapetis, C., Roy, A. and Price, T. (2023) Primary Site and Treatment Impact in Unresectable Metastatic Colorectal Cancer. Expert Review of Anticancer Therapy, 23, 617-623. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Ameen, S., Wong, M.C., Turner, P. and Yee, K.C. (2023) Improving Colorectal Cancer Screening-Consumer-Centred Technological Interventions to Enhance Engagement and Par-ticipation amongst Diverse Cohorts. Clinics and Research in Hepatology and Gastroenterology, 47, Article ID: 102064. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Chiu, L.S. and Calderwood, A.H. (2023) Noninvasive Colorectal Cancer Prevention Options in Older Adults. Journal of Clinical Gastroenterology, 57, 855-862. [Google Scholar] [CrossRef]
|
|
[63]
|
Phen, C., Berens, D., Moriarty, K., Ng, K., Sengupta, A. and Rojas, I. (2022) Polygenic Early-Onset Colorectal Cancer in Pediatric Patients. Pediatric Blood & Cancer, 69, e29790. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Liu, T.Y., Hu, C.C., Han, C.Y., et al. (2023) IGF2BP2 Promotes Colorectal Cancer Progression by Upregulating the Expression of TFRC and Enhancing Iron Metabolism. Biology Di-rect, 18, Article No. 19. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Taglialegna, A. (2023) Commensal Bacteria Fight Colorectal Cancer. Nature Reviews Microbiology, 21, Article No. 276. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Puli, A.V., Lussiez, A., MacEachern, M., et al. (2023) Barriers to Colorectal Cancer Screening in US Immigrants: A Scoping Review. Journal of Surgical Research, 282, 53-64. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Graham, H., Kauffman, R. and Khaliq, W. (2022) Colorectal Cancer Screening Prevalence, Perceived Barriers, and Preference for Screening Colonoscopy among Hospitalized Women. Turkish Journal of Gastroenterology, 33, 901-908. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Jiang, Z., Sha, G., Zhang, W., et al. (2023) The Huge Potential of Tar-geting Copper Status in the Treatment of Colorectal Cancer. Clinical and Translational Oncology, 25, 1977-1990. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Liang, Z., Xie, H., Shen, W., et al. (2022) The Synergism of Natural Compounds and Conventional Therapeutics against Colorectal Cancer Progression and Metastasis. Frontiers in Bioscience (Landmark Ed), 27, Article No. 263. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Marks, J.H., Frenkel, J.L., D’Andrea, A.P. and Greenleaf, C.E. (2011) Maximizing Rectal Cancer Results: TEM and TATA Techniques to Expand Sphincter Preservation. Surgical Oncology Clinics of North America, 20, 501-520. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Zhang, H., Zhang, Y.S., Jin, X.W., Li, M.Z., Fan, J.S. and Yang, Z.H. (2013) Transanal Single-Port Laparoscopic Total Mesorectal Excision in the Treatment of Rectal Cancer. Techniques in Coloproctology, 17, 117-123. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
de Lacy, A.M., Rattner, D.W., Adelsdorfer, C., et al. (2013) Transanal Natural Orifice Transluminal Endoscopic Surgery (NOTES) Rectal Resection: “Down-to-Up” Total Mesorectal Excision (TME) Short-Term Outcomes in the First 20 Cases. Surgical Endoscopy, 27, 3165-3172. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Kano, Y., Suenaga, M. and Uetake, H. (2023) Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer. Current Oncology, 30, 6546-6558. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Lin, W.C., Lin, C.C., Lin, Y.Y., et al. (2022) Molecular Actions of Exosomes and Their Theragnostics in Colorectal Cancer: Current Findings and Limitations. Cellular Oncology (Dordr), 45, 1043-1052. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Atallah, S., Martin-Perez, B., Albert, M., et al. (2014) Transanal Minimally Invasive Surgery for Total Mesorectal Excision (TAMIS-TME): Results and Experience with the First 20 Pa-tients Undergoing Curative-Intent Rectal Cancer Surgery at a Single Institution. Techniques in Coloproctology, 18, 473-480. [Google Scholar] [CrossRef] [PubMed]
|